Market Overview:
The global hydrogel-based drug delivery system market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for novel and advanced drug delivery systems, rising prevalence of chronic diseases, and growing focus on R&D activities by pharmaceutical companies. Based on type, the global hydrogel-based drug delivery system market can be segmented into natural system and synthesis system. The natural system segment is expected to account for a larger share of the market in 2018 owing to its advantages such as biocompatibility, non-toxicity, and easy scalability. By application, the subcutaneous application segment is expected to account for a larger share of the global hydrogel-based drug delivery system market in 2018 due to its growing use in various therapeutic areas such as diabetes mellitus and rheumatoid arthritis.
Product Definition:
A hydrogel-based drug delivery system is a type of drug delivery system that uses hydrogels as the carrier for the drug. Hydrogels are water-containing polymers that can absorb large amounts of water, making them excellent carriers for drugs. Their high water content also makes them good at delivering moisture to the skin, which can be beneficial in treating conditions like dry skin or eczema. Additionally, hydrogel-based systems are often nonirritating and nonallergenic, making them ideal for use on sensitive skin.
Natural System:
Natural system is the body's own immune and inflammatory response to an injury or infection. The natural system includes four types of cells: macrophages, dendritic cells, natural killer cells and neutrophils. These are the white blood cells that find their way into damaged tissues to devour pathogens and dead bodies.
Synthesis System:
A synthesis system is a chemical procedure used to derive a wide range of chemicals. It involves the combination of reagents and catalysts in fixed proportions or reactions at defined temperatures and pressures. The most commonly used reaction types are hydrolysis, condensation, oxidation, reduction, and elimination.
Application Insights:
Based on application, the global hydrogel-based drug delivery system market is segmented into subcutaneous, ocular, oral cavity, topical and other. The subcutaneous region dominated the overall market in terms of revenue in 2017 owing to increasing usage of these products for delivering drugs at the desired site of action. This method is most commonly used for local injections around muscles and joints which are widely accepted across various patient groups.
The oral cavity region is expected to witness significant growth over the forecast period due to increasing usage as a drug delivery device for dental procedures such as tooth extraction or filling.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing R&D investments by various companies and rising healthcare expenditure. In addition, high prevalence of chronic diseases such as diabetes and cancer is also anticipated to drive regional growth over the forecast period.
Asia Pacific is estimated to be fastest-growing region during the same period due to factors such as growing economy, improving healthcare infrastructure, increase in disposable income & consumer awareness about early diagnosis of chronic diseases coupled with rising demand for cost-effective treatment options for patients across this region. Moreover hydrogel based drug delivery systems offer a noninvasive method of drug delivery which has gained significant popularity among patients & physicians alike thereby driving regional growth over past few years (last 7 years).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the increasing number of geriatric patients, rising prevalence of chronic diseases, and technological advancements in surgical procedures. Hydrogel-based drug delivery systems are increasingly being used in minimally invasive surgeries as they offer several advantages over traditional drug delivery methods such as reduced invasiveness, shorter hospital stays, and faster recovery times.
- Growing demand for targeted drug delivery: The global market for targeted drug delivery is expected to grow at a CAGR of 9% from 2016 to 2021. This can be attributed to the growing need for improved patient outcomes and increased efficiency in the pharmaceutical industry. Hydrogel-based drug delivery systems offer an efficient and non-invasive means of delivering drugs directly to the target site, thus resulting in better patient outcomes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydrogel-based Drug Delivery System Market Research Report
By Type
Natural System, Synthesis System
By Application
Subcutaneous, Ocular, Oral Cavity, Topical, Other
By Companies
GlaxoSmithKline, Alliance Pharmaceuticals Limited, Oraldent, Ashland, Johnson & Johnson, Pfizer, Inc., Gilead Sciences, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Hydrogel-based Drug Delivery System Market Report Segments:
The global Hydrogel-based Drug Delivery System market is segmented on the basis of:
Types
Natural System, Synthesis System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Subcutaneous, Ocular, Oral Cavity, Topical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Alliance Pharmaceuticals Limited
- Oraldent
- Ashland
- Johnson & Johnson
- Pfizer, Inc.
- Gilead Sciences
- Teva Pharmaceutical Industries
- Valeant Pharmaceuticals International
Highlights of The Hydrogel-based Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natural System
- Synthesis System
- By Application:
- Subcutaneous
- Ocular
- Oral Cavity
- Topical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydrogel-based Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A hydrogel-based drug delivery system is a type of medical device that uses a gel to deliver medications and other treatments to the body. Hydrogels are made from water, polymer, and sometimes additives like surfactants. They are often soft and flexible, which makes them easy to insert into the body. Hydrogel-based systems can be used for various purposes, including delivering medication directly to the site of treatment (topical application), as an implantable device for long-term therapy (subcutaneous or intramuscular injection), or as a delivery system for gene therapies.
Some of the major players in the hydrogel-based drug delivery system market are GlaxoSmithKline, Alliance Pharmaceuticals Limited, Oraldent, Ashland, Johnson & Johnson, Pfizer, Inc., Gilead Sciences, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International.
The hydrogel-based drug delivery system market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydrogel-based Drug Delivery System Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Hydrogel-based Drug Delivery System Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Hydrogel-based Drug Delivery System Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Hydrogel-based Drug Delivery System Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Hydrogel-based Drug Delivery System Market Size & Forecast, 2020-2028 4.5.1 Hydrogel-based Drug Delivery System Market Size and Y-o-Y Growth 4.5.2 Hydrogel-based Drug Delivery System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Natural System
5.2.2 Synthesis System
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Subcutaneous
6.2.2 Ocular
6.2.3 Oral Cavity
6.2.4 Topical
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydrogel-based Drug Delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydrogel-based Drug Delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Natural System
9.6.2 Synthesis System
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Subcutaneous
9.10.2 Ocular
9.10.3 Oral Cavity
9.10.4 Topical
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Natural System
10.6.2 Synthesis System
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Subcutaneous
10.10.2 Ocular
10.10.3 Oral Cavity
10.10.4 Topical
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Natural System
11.6.2 Synthesis System
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Subcutaneous
11.10.2 Ocular
11.10.3 Oral Cavity
11.10.4 Topical
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Natural System
12.6.2 Synthesis System
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Subcutaneous
12.10.2 Ocular
12.10.3 Oral Cavity
12.10.4 Topical
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Natural System
13.6.2 Synthesis System
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Subcutaneous
13.10.2 Ocular
13.10.3 Oral Cavity
13.10.4 Topical
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydrogel-based Drug Delivery System Market: Competitive Dashboard
14.2 Global Hydrogel-based Drug Delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Alliance Pharmaceuticals Limited
14.3.3 Oraldent
14.3.4 Ashland
14.3.5 Johnson & Johnson
14.3.6 Pfizer, Inc.
14.3.7 Gilead Sciences
14.3.8 Teva Pharmaceutical Industries
14.3.9 Valeant Pharmaceuticals International